z-logo
open-access-imgOpen Access
Gut Microbiota and Immune Responses
Author(s) -
Tobin Lee
Publication year - 2022
Publication title -
science insights
Language(s) - English
Resource type - Journals
eISSN - 2372-8191
pISSN - 2329-5856
DOI - 10.15354/si.22.re022
Subject(s) - immune system , biology , gut flora , foxp3 , immunology , microbiome , il 2 receptor , antimicrobial peptides , microbiology and biotechnology , t cell , antimicrobial , bioinformatics
The gut is the body’s largest immune organ, consisting of both hematopoietic (macrophages, dendritic cells, and T cells) and non-hematopoietic cells (epithelial cells, Paneth cells, and goblet cells). It is home to hundreds of millions of microorganisms, which collaborate with the host immune system to maintain the internal environment’s homeostasis. The gut microbiome plays a critical role in the development of inflammatory responses (including autoimmune diseases, allergies, etc.). The gut microbiota has a direct effect on the maturation of the host immune system, inducing immunoglobulin A (IgA), and regulating CD4+ T cells, including Th1, Th17, and regulatory T cells (CD4+, CD25+, Foxp3+). Along with the expression of antimicrobial peptides (AMPs), numerous molecules produced by flora may influence these immune responses. Numerous basic and clinical studies have established that controlling the gut microbiota is an effective method for treating and controlling disease. Once these mechanisms are fully understood, probiotics/prebiotics may be used to regulate the gut microbiota in order to treat diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here